Physician profile
John Watson
NPI 1962662312
$3,633.53
in general payments reported to CMS, 2019-2025
34 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $953 · 2020: $885 · 2021: $1,344 · 2022: $197 · 2023: $30.56 · 2024: $49.40 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $383.89 | 2019-2025 | |
| Abbvie INC. | $360.60 | 2019-2025 | |
| Astellas Pharma US INC | $350.00 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $278.04 | 2019-2022 | |
| Antares Pharma, INC. | $210.96 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $205.76 | 2019-2025 | |
| Janssen Biotech, INC. | $198.33 | 2019-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $181.86 | 2020-2022 | |
| Stryker Corporation | $137.94 | 2019 | |
| Endo Pharmaceuticals INC. | $137.29 | 2019-2021 | |
| Boston Scientific Corporation | $100.98 | 2019-2025 | Rezum Generator |
| 180 Medical, INC. | $100.37 | 2019-2022 | |
| Amgen INC. | $99.18 | 2019-2021 | |
| Myovant Sciences INC. | $87.47 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $82.69 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $77.35 | 2019-2021 | |
| Neotract INC. | $67.18 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $57.88 | 2020-2021 | |
| Clarus Therapeutics INC. | $56.76 | 2021 | |
| Acerus Pharmaceuticals Corporation | $54.23 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $51.76 | 2020-2021 | |
| Ambu INC. | $48.40 | 2020 | |
| Urovant Sciences INC | $42.24 | 2021-2022 | |
| Procept Biorobotics Corporation | $42.18 | 2021 | |
| Ferring Pharmaceuticals INC. | $41.16 | 2019-2020 | |
| Teleflex LLC | $29.38 | 2021 | |
| Blue Earth Diagnostics | $25.76 | 2019-2021 | |
| Olympus America INC. | $21.52 | 2025 | Hd Camera Head |
| Axonics, INC. | $18.95 | 2021 | |
| Photocure INC | $18.86 | 2019 | |
| Sumitomo Pharma America, INC. | $18.32 | 2025 | Gemtesa |
| Urogen Pharma, INC. | $15.94 | 2024 | |
| Verity Pharmaceuticals INC. | $15.31 | 2021 | |
| Foundation Medicine, INC. | $14.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.